KU-60019 CAS NO.925701-49-1

ku-60019 is a potent and selective atm inhibitor. ku-60019 is 10-fold more effective than ku-55933 at blocking radiation-induced phosphorylation of key atm targets in human glioma cells. as expected, ku-60019 is a highly effective radiosensitizer of human glioma cells. ku-60019 inhibits the dna damage response, reduces akt phosphorylation and prosurvival signaling, inhibits migration and invasion, and effectively radiosensitizes human glioma cells (mol cancer ther. 2009 oct;8(10):2894-902. ).

tianjin kailiqi biopharma technology co., ltd, is a professional manufacturer specialized in the production and distribution of active pharmaceutical ingredients and intermediates. our company has strong r&d ability and production experience to provide the customers new apis. we specialize in developing innovative processes for the synthesis of a wide range of products. we also undertake custom synthesis and contract manufacturing.if you are interest in,pls contact with me,we also have lab,specifical in some hard synthesis.